drugset

drugset / Trial / NCT00436059

The Efficacy of Velcade on Bone Tissue During Myelomatosis (Bone Marrow Cancer)

NCT00436059 ↗

Phase 2 Completed 20 enrolled Vejle Hospital Odense University Hospital · collab

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The primary objective of the the study is to investigate the changes in bone remodeling during Velcade treatment.

Timeline

Start: 2007-02
Primary completion: 2009-07
Completion: 2009-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Bortezomib	Small molecule	—	—

Indications